Journal of Clinical Epidemiology
Volume 58, Issue 2 , Pages 130-137 , February 2005

The generalizability of observational data to elderly patients was dependent on the research question in a systematic review

  • Cary P. Gross

      Affiliations

    • Section of General Internal Medicine, Department of Medicine, Yale-New Haven Hospital Center for Outcomes Research and Evaluation, 20 York St., New Haven, CT 06504, USA
    • Section of Cardiovascular Medicine, Department of Medicine, Yale-New Haven Hospital Center for Outcomes Research and Evaluation, 20 York St., New Haven, CT 06504, USA
    • Corresponding Author InformationCorresponding author. Yale University School of Medicine, Primary Care Center, 333 Cedar Street, PO Box 208025, New Haven, CT 06520. Tel.: 203-688-8588; fax: 203-688-4092.
    • ,
  • Pushkal P. Garg

      Affiliations

    • Division of General Internal Medicine, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    • Department of Health Care Policy, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
    • Millennium Pharmaceuticals, Inc., 40 Landsdowne St, Cambridge, MA 02139, USA
    • ,
  • Harlan M. Krumholz

      Affiliations

    • Section of Cardiovascular Medicine, Department of Medicine, Yale-New Haven Hospital Center for Outcomes Research and Evaluation, 20 York St., New Haven, CT 06504, USA
    • Section of Health Policy and Administration, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06510, USA

,Accepted 9 May 2004.

References 

  1. Gross C, Mallory R, Heiat A, Krumholz H. Reporting the recruitment process in clinical trials: who are these patients and how did they get there?. Ann Intern Med. 2002;137:10–16
  2. Britton A, McKee M, Black N, McPherson K, Sanderson C, Bain C. Threats to applicability of randomised trials: exclusions and selective participation. J Health Serv Res Policy. 1999;4:112–121
  3. Rathore SS, Weinfurt KP, Gross CP, Krumholz HM. Validity of a simple ST-elevation acute myocardial infarction risk index: are randomized trial prognostic estimates generalizable to elderly patients?. Circulation. 2003;107:811–816
  4. Ellenberg S, Foulkes M. The utility of large simple trials in the evaluation of AIDS treatment strategies. Stat Med. 1994;13:405–415
  5. Gore J, Granger C, Simoons M, Sloan M, Weaver W, White H. Stroke after thrombolysis: mortality and functional outcomes in the GUSTO-1 trial. Circulation. 1995;92:2811–2818
  6. Brass L, Lichtman J, Wang Y, Gurwitz J, Radford M, Krumholz H. Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction. Stroke. 2000;31:1802–1811
  7. Pfisterer M, Cox J, Granger C, Brener S, Naylor C, Califf R. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-1 experience. J Am Coll Cardiol. 1998;32:634–640
  8. Krumholz H, Radford M, Wang Y, Chen J, Heiat A, Marciniak T. National Use and Effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction. JAMA. 1998;280:623–629
  9. Pilote L, Califf R, Sapp S, Miller D, Mark D, Weaver W. Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med. 1995;333:565–572
  10. Lee K, Woodlief L, Topol E, Weaver WD, Betriu A, Col J, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Circulation. 1995;91:1659–1668
  11. Krumholz H, Chen J, Wang Y, Radford M, Chen Y, Mariniak T. Comparing AMI mortality among hospitals in patients 65 years of age and older. Circulation. 1999;99:2986–2992
  12. Rathore SS, Berger AK, Weinfurt KP, et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation. 2000;101:969–974
  13. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997;30:406–413
  14. Weaver W, White H, Wilcox R, Aylward P, Morris D, Guerci A. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. JAMA. 1996;275:777–782
  15. Gan S, Beaver S, Houck P, MacLehose M, Lawson H, Chan L. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med. 2000;343:8–15
  16. Rathore S, Wang Y, Radford M, Ordin D, Krumholz H. Sex differences in cardiac catheterization after acute myocardial infarction: the role of procedure appropriateness. Ann Intern Med. 2002;137:487–493
  17. Sheifer S, Rathore S, Bersh B, et al. Time to presentation with acute myocardial infarction in the elderly. Circulation. 2000;102:1651–1656
  18. Gibler W, Armstron P, Ohman E, Weaver W, Stebbins A, Gore J. Persistence of delays in presentation and treatment for patients with acute myocardial infarction. Ann Emerg Med. 2002;39:123–130
  19. Berger A, Radfort M, Krumholz H. Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: analysis of the cooperative cardiovascular project. Am Heart J. 2000;139:985–992
  20. Krumholz H, Radford M, Wang Y, Chen J, Marciniak T. Early beta-blockers for acute myocardial infarction in elderly patients. Ann Intern Med. 1999;131:648–654
  21. Teo K, Yusuf S, Furberg C. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA. 1993;270:1589–1595
  22. The GUSTO Investigators . An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673–682
  23. Guadagnoli E, Landrum MB, Peterson EA, Gahart MT, Ryan TJ, McNeil BJ. Appropriateness of coronary angiography after myocardial infarction among Medicare beneficiaries: managed care versus fee for service. N Engl J Med. 2000;343:1460–1466
  24. Lambert PC, Sutton AJ, Abrams KR, Jones DR. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol. 2002;55:86–94
  25. Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI. Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med. 2002;21:371–387
  26. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med. 2002;347:1403–1411
  27. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003;289:871–878
  28. www.grants2.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html. Accessed May 14, 2003.
  29. www.nhlbi.nih.gov/resources/deca/directry.htm. Accessed May 15, 2003.

 Dr. Gross was supported by a Cancer Prevention, Control and Population Sciences Career Development Award (1K07CA-90402) and the Claude D. Pepper Older Americans Independence Center at Yale (P30AG21342). Dr. Garg is employed by Millennium Pharmaceuticals, Inc. (Cambridge, MA), which did not provide support for this study.

PII: S0895-4356(04)00250-1

doi: 10.1016/j.jclinepi.2004.10.001

Journal of Clinical Epidemiology
Volume 58, Issue 2 , Pages 130-137 , February 2005

Article Tools